Patents
Patents for C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof (42,273)
03/2009
03/04/2009EP1045861B1 Bispecific targeting moiety comprising an antibody to carcinoembryonic antigen (cea) and the ligand-binding region of the il13 receptor alpha subunit
03/04/2009EP0869974B1 Compounds with growth hormone releasing properties
03/04/2009CN101379077A Small peptidic and peptido-mimetic affinity ligands for factor VIII and factor VIII-like proteins
03/04/2009CN101379075A Synthesis of glucagon-like peptide
03/03/2009US7498404 Purified, heat stable, amino terminus-methylated, carboxy-terminus reduced peptide isolated from Brevibacillus comprising {4-methyl-4-[-2-butenyl]-4,N-methyl-Threonine}-leucine-ornithine-isoleucine-valine-valine-lysine-valine-lysine-tyrosine-leucine-valine alcohol; immunomodulators; infections
03/03/2009US7498403 Peptides capable of binding to titanium silver silicone
03/03/2009US7498310 Applying a water in oil emulsion of a tetrapeptide: H2N-Valine-Valine-Arginine-Proline or one of its amide derivatives
03/03/2009US7498306 E4 or F4 and Bcl-2 peptides of small dimension (less than 30 amino acids) that bind a PP2A holoenzyme or one of its sub-units, particularly useful as anticancer, antiviral and antiparasitic agents
03/03/2009US7498302 Analogues of rachelmycin and the duocarmycins that are potent cytotoxins containing a benzodipyrrole or naphthopyrrole ring; anticancer agents
03/03/2009US7498162 A gene expressed polypeptide is used in food, for treating food allergy
03/03/2009US7498138 Multimerization of HIV-1 Vif protein as a therapeutic target
03/03/2009US7498037 Expression vector comprising nucleotide sequences coding malarial proteins for use as tool in generating vaccines against plasmodial infection; immunotherapy; antimalarial agents
03/03/2009US7498025 Targeted bifunctional molecules and therapies based thereon
03/03/2009US7498021 Peptide that binds to integrins
03/03/2009CA2420222C Orally administered peptides to ameliorate atherosclerosis
02/2009
02/26/2009WO2009026233A2 Self assembling peptide systems and methods
02/26/2009WO2009026218A2 Identification and use of peptide inhibitors of protein synthesis
02/26/2009WO2009026155A2 Antimicrobial activity of bovine bactericidal/permeability-increasing protein (bpi) - derived peptides against gram-negative bacterial mastitis isolates
02/26/2009WO2009025300A1 Peptide capable of binding to immunoglobulin
02/26/2009WO2009025196A1 Foxm1 peptide and medicinal agent comprising the same
02/26/2009WO2009025117A1 Cdca1 peptide and pharmaceutical agent comprising the same
02/26/2009WO2009025116A1 Cdh3 peptide and medicinal agent comprising the same
02/26/2009WO2009025080A1 Colorectal cancer marker polypeptide, and method for diagnosis of colorectal cancer
02/26/2009WO2009024571A1 Blood coagulation factor inhibitors
02/26/2009WO2009024528A1 Use of cyclic depsipeptides to inhibit kallikrein 7
02/26/2009WO2009024070A1 Detection and quantitation of urine gelsolin
02/26/2009WO2009006638A3 Peptides facilitating retrograde transport and their uses
02/26/2009WO2008109653A3 Peptides specific for human blood outgrowth endothelial cells
02/26/2009WO2008099285A3 Control of transport properties to and from nanoparticle surfaces
02/26/2009US20090055975 Plant virus transmission inhibitor and methods
02/26/2009US20090054349 Peptides for Promoting Hair Growth and Improving Wrinkle and Cosmetic Compositions Comprising the same
02/26/2009US20090054348 Bi-dentate compounds as kinase inhibitors
02/26/2009US20090054347 Kinin b1 receptor peptide agonists and uses thereof
02/26/2009US20090054345 Template-Fixed Beta-Hairpin Peptidomimetics With Protease Inhibitory Activity
02/26/2009US20090054344 Anti-angiogenic proteins and fragments and methods of use thereof
02/26/2009US20090054342 Bioactive peptides and method of using same
02/26/2009US20090054333 Peptide inhibitors of cyclin-dependent kinase activity and uses thereof
02/26/2009US20090054332 Thombopoietin peptide conjugates
02/26/2009US20090054325 Compositions and methods for suppressing axonal growth inhibition
02/26/2009US20090054323 Ang-2 inhibitor peptides; use treating tumors, eye disorders, bone disorders, psoriasis; angiogenesis inhibitors; amino acid sequence WDPWT
02/26/2009US20090054317 Polyvalent inhibitors of pathogens
02/26/2009US20090054312 SMIPs: Small molecule inhibitors of p27 depletion in cancers and other proliferative diseases
02/26/2009US20090054309 Peptidic vasopressin receptor agonists
02/26/2009US20090054300 Using protein profiles aspredictive tools in prognosis and treatment of immune related disorders
02/26/2009US20090053750 Methods and compositions for identifying a cellular immune response against prostate cancer
02/26/2009US20090053723 Peripherin and Neurofilament Light Protein Splice Variants in Amyotrophic Lateral Sclerosis (ALS)
02/26/2009US20090053257 Replikin peptides and uses thereof
02/26/2009US20090053202 Peptide fragment of LYVE-1 and antibody against the same
02/26/2009US20090053151 Antibacterial peptides and analogues thereof
02/26/2009DE112007001030T5 Amyloid-ß-Fibrillogenese-inhibierendes Peptid Amyloid-beta fibrillogenesis-inhibiting peptide
02/26/2009CA2696701A1 Cdca1 peptide and pharmaceutical agent comprising the same
02/26/2009CA2696597A1 Foxm1 peptide and medicinal agent comprising the same
02/26/2009CA2696591A1 Cdh3 peptide and medicinal agent comprising the same
02/25/2009EP2028191A1 Peptides and compounds that bind to a receptor
02/25/2009EP2028187A1 Human and mouse targeting peptides identified by phage display
02/25/2009EP1471920B1 Process for preparing water-soluble phosphonooxymethyl derivatives of alcohol and phenol
02/25/2009EP1247532B1 Composition promoting lacrimal secretion
02/25/2009CN101374860A Synthetic peptides for use as inhibitors of neurotransmitter secretion and as inducers of cellular relaxation
02/25/2009CN101374857A Novel T-helper antigenic determinant (THD) peptides
02/25/2009CN101374856A Inhibiting tumor cell invasion, metastasis and angiogenesis
02/25/2009CN101372511A Immunogenic peptide composition for the prevention and treatment of alzheimer's disease
02/25/2009CN101372508A Polypeptide and use thereof
02/25/2009CN101372507A Signal conotoxin mutant polypeptides compound lt14a-7, preparation and use thereof
02/25/2009CN101372506A Novel process for preparing eptifibatide by purification
02/25/2009CN101372505A Method for preparing desmopressin acetate
02/25/2009CN101372504A Method for purifying desmopressin
02/24/2009US7494988 Inhibitors of serine proteases, particularly hepatitis C virus NS3 protease
02/24/2009US7494980 administering a decapeptide of the sequence NH2-Iys-lys-val-val-phe-lys-val-lys-phe-lys-CONH2; biofilm formation inhibition; anticaries agent
02/24/2009US7494979 Method for treating congestive heart failure and other disorders
02/24/2009US7494973 Therapeutic fibrin-derived peptides and uses thereof
02/24/2009US7494767 Assay for TSG101 as inhibitors of HIV production
02/24/2009US7494655 antigenic peptides, antibodies and carriers, diluents, excipients, adjuvants or auxiliary agents, use for inhibiting the formation of beta-amyloid; treatment of Alzheimer's disease or Down's syndrome
02/24/2009CA2324380C Assay for the diagnosis of schizophrenia based on a new peptide
02/24/2009CA2245497C Peptide immunogens for vaccination against and treatment of allergy
02/19/2009WO2009023306A2 Targeting host proteinases as a therapeutic strategy against viral and bacterial pathogens
02/19/2009WO2009022652A1 Lck-derived peptide useful for cancer vaccine therapy on cancer patient who is positive for hla-a3 supertype allele
02/19/2009WO2009022339A1 Polypeptides, matrices, hydrogels and methods of using same for tissue regeneration and repair
02/19/2009WO2009022154A2 Peptide with multiple epitopes
02/19/2009WO2008152252A3 Rumc peptides with antimicrobial activity
02/19/2009WO2008142319A3 Peptide analogues of melanocortin receptors
02/19/2009WO2008133908A3 Suspension formulations of insulinotropic peptides and uses thereof
02/19/2009US20090048428 inclusion body tags; Expression of the fusion peptide in a host cell results in a product that is insoluble and contained within inclusion bodies in the cell and/or cell lysate
02/19/2009US20090048180 Sustained-release preparation
02/19/2009US20090048178 Lps or lipid a binding agent and novel peptide
02/19/2009US20090048175 Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
02/19/2009US20090048171 Treatment of viral infections
02/19/2009US20090048170 Target for anti-angiogenesis therapy
02/19/2009US20090048168 Inhibitors of bcl-2
02/19/2009US20090048166 Peptide dimer bonded to polyethylene glycol through amide groups; insufficient or defective red blood cell production; anemia; genetic discorder; blood disorders; erythropoietin receptor agonists
02/19/2009US20090048161 Cytokine receptor modulators and uses thereof
02/19/2009US20090048149 Antagonists of the bradykinin B1 receptor
02/19/2009US20090048147 Nitrogen-based linkers for attaching modifying groups to polypeptides and other macromolecules
02/19/2009US20090047741 Compositions and methods comprising a ligand of chemerin R
02/19/2009US20090047654 Polymer affinity matrix, a method for the production and use thereof
02/19/2009US20090047360 Bone morphogenic protein binding peptide
02/19/2009US20090047335 Anti-angiogenic peptides and methods of use thereof
02/19/2009US20090047302 Chimaeric Human Papillomavirus 16 L1 Virus Like Particles and a Method for Preparing the Particles
02/19/2009CA2695971A1 Polypeptides, matrices, hydrogels and methods of using same for tissue regeneration and repair
02/19/2009CA2687024A1 Targeting host proteinases as a therapeutic strategy against viral and bacterial pathogens
02/18/2009EP2024389A2 Imaging agent